Benjamin Graham fit · Inversión deep-value defensiva
Is Neurocrine Biosciences Inc (NBIX) a Benjamin Graham Stock?
Meets 3/7 Graham criteria — partially qualifies.
55/100
CSeñales mixtas
3/7 criterios cumplidos
Los criterios de Benjamin Graham, aplicados a NBIX
P/E ≤ 15
clave—
P/B ≤ 1.5
clave44.4x
Current ratio ≥ 2
3.4x
Debt / Equity ≤ 1
0.0x
Cómo se valora NBIX en otras estrategias
Datos financieros en vivo
Cap. mercado
$15.76B
PER (TTM)
22.6x
ROIC (TTM)
13.68%
Margen bruto
98.17%
Otros análisis Benjamin Graham
Preguntas frecuentes
What is NBIX's Benjamin Graham fit score?
NBIX scores 55/100 on our Benjamin Graham fit engine — grade C. Meets 3/7 Graham criteria — partially qualifies.
Does Benjamin Graham actually own NBIX?
Our score is computed from financial fundamentals against Benjamin Graham's published criteria. We don't claim that Benjamin Graham personally owns or recommends NBIX.
How often is this score updated?
NBIX's Benjamin Graham fit score is recomputed daily from the latest TTM financials.
Herramienta educativa, no es asesoramiento financiero. Las puntuaciones se calculan a partir de datos financieros públicos contra los criterios publicados de cada estrategia de inversión. No afirmamos que Benjamin Graham posea o recomiende NBIX personalmente.